Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Pediatr. 2021 Mar 24;234:236–244.e2. doi: 10.1016/j.jpeds.2021.03.028

Table 5.

Microbiologic Characteristics

Characteristic All Septic Arthritis Osteomyelitis Both
N Median (IQR) N Median (IQR) N Median (IQR) N Median (IQR)
Duration of bacteremia (days) 171 2.0 (1.0, 4.0) 16 1.5 (1.0, 2.0) 92 2.0 (1.0, 4.0) 63 3.0 (2.0, 4.0)
 Bacteremia 419 171 (41%) 118 16 (14%) 203 92 (45%) 98 63 (64%)
 Persistent bacteremia (>72 h) 419 53 (13%) 118 3 (3%) 203 26 (13%) 98 24 (24%)
Organism identified by blood or infection site culturea 448 277 (62%) 132 50 (38%) 213 144 (68%) 103 83 (81%)
 None 171 (38%) 82 (62%) 69 (32%) 20 (19%)
S. aureus 228 (51%) 25 (19%) 127 (60%) 76 (74%)
S. pyogenes 21 (5%) 9 (7%) 7 (3%) 5 (5%)
K. kingae 5 (1%) 3 (2%) 2 (1%) 0 (0%)
S. pneumoniae 6 (1%) 4 (3%) 2 (1%) 0 (0%)
H. influenzae 2 (0%) 2 (2%) 0 (0%) 0 (0%)
Salmonella spp. 4 (1%) 0 (0%) 3 (1%) 1 (1%)
 Other organismb 14 (3%) 8 (6%) 4 (2%) 2 (2%)
S. aureus antibiotic resistance 228 25 127 76
 Methicillin 114 (50%) 10 (40%) 61 (48%) 43 (57%)
 Clindamycin 19 (8%) 3 (12%) 11 (9%) 5 (7%)
 TMP/SMX 3 (1%) 1 (4%) 1 (1%) 1 (1%)
 Erythromycin 126 (55%) 11 (44%) 70 (55%) 45 (59%)
  MRSA resistance 114 10 61 43
   Clindamycin 8 (7%) 2 (20%) 4 (7%) 2 (5%)
   TMP/SMX 1 (1%) 0 (0%) 0 (0%) 1 (2%)
   Doxycycline 0 (0%) 0 (0%) 0 (0%) 0 (0%)
   Erythromycin 90 (79%) 9 (90%) 49 (80%) 32 (74%)
  MSSA resistance 114 15 66 33
   Clindamycin 11 (10%) 1 (7%) 7 (11%) 3 (9%)
   TMP/SMX 2 (2%) 1 (7%) 1 (2%) 0 (0%)
   Erythromycin 36 (32%) 2 (13%) 21 (32%) 13 (39%)
a

Three subjects had polymicrobial infections

b

Other organisms include coagulase negative Staphylococcus, Group C Streptococcus, Group G Streptococcus, viridans group Streptococcus, Leclercia adecarboxylata, Enterobacter asbunae, Enterobacter cloacae, Pseudomonas fluorescens, Bacillus spp.